In this study, we analyzed the risk factors for thrombotic events in 125 patients with PV and ET, applied next-generation sequencing technology to detect 31 MPN-related gene mutations, and observed that the TET2 mutation is an independent risk factor for thrombosis in ET patients, but no such association was observed in PV patients. The gene discussed is TET2; the disease is myeloproliferative neoplasm.